Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

There is some evidence to suggest that transforming growth factor-beta (TGF-beta) mediates the cytostatic effects of the anti-oestrogen tamoxifen. In this study we have demonstrated that alpha-interferon has a significant anti-proliferative effect on the oestrogen receptor-positive human breast cancer cell line ZR-75. There is decreased phenotypic expression of the oestrogen receptors (to about 30% of control values) and increased TGF-beta mRNA. Under the growth conditions used here, ZR-75 cells had approximately 5800 TGF-beta binding sites per cell, with an apparent dissociation constant of 70 pm, and we have shown that the anti-proliferative effects of alpha-interferon can be reduced by 60% by co-treating the cells with a TGF-beta polyclonal antibody. The cytostatic effects of alpha-interferon may therefore be mediated by TGF-beta in this human breast cancer cell line.

Original publication

DOI

10.1677/jme.0.0020131

Type

Journal article

Journal

J Mol Endocrinol

Publication Date

03/1989

Volume

2

Pages

131 - 136

Keywords

Antibodies, Antineoplastic Agents, Breast Neoplasms, Cell Line, Dose-Response Relationship, Drug, Female, Humans, Interferon-gamma, Iodine Radioisotopes, Phenotype, RNA, Messenger, Receptors, Estrogen, Transforming Growth Factors, Tumor Cells, Cultured